Related Experiment Video
Updated: Oct 15, 2025

07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
998
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas
Roberto Alva-Ruiz1, Mark J Truty2
1Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, MN, USA.
Annals of Surgical Oncology
|October 27, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
141
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
141
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

